Figure 1 (Tevimbra 01)
Tevimbra Injection, Solution, Concentrate
Product Images NDC 72579-121
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tevimbra (NDC 72579-121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Beone Medicines Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (10 mL Vial Carton)
This description provides information about "TEVIMBRA® Tislelizumab-jsgr injection" containing 100 mg/10 mL (10 mg/mL) for intravenous infusion. The composition includes tislelizumab-sgr, citric acid monohydrate, histidine, L-histidine hydrochloride monohydrate, polysorbate 20, sodium citrate, trehalose, and Water for Injection, USP. It is advised to refrigerate between 2°C to 8°C (36°F to 46°F) and protect from light. The medication guide is included, and unused portions should be discarded.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
